Clara Meisner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BOSTON--(BUSINESS WIRE)--Dec 18, 2023--

Commodore Capital LP boosted its position in shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN – Free Report) by 8.4% in the 1st quarter, HoldingsChannel reports. The fund owned 2,189,659 shares of the company’s stock after acquiring an additional 169,493 shares during the period. Viridian Therapeutics accounts for about 8.5% of Commodore Capital LP’s portfolio, making the […]

Hood River Capital Management LLC bought a new stake in Viridian Therapeutics, Inc. (NASDAQ:VRDN – Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 566,498 shares of the company’s stock, valued at approximately $14,412,000. Hood River Capital Management LLC owned […]

Hood River Capital Management LLC purchased a new stake in shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN – Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 566,498 shares of the company’s stock, valued at approximately $14,412,000. Several other hedge […]

Viridian Therapeutics (NASDAQ:VRDN – Free Report) had its target price reduced by Wells Fargo & Company from $46.00 to $39.00 in a report published on Wednesday, Marketbeat.com reports. They currently have an overweight rating on the stock. VRDN has been the subject of several other reports. Royal Bank of Canada began coverage on shares of […]